Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

https://soho2018.org/

Session I: Chronic Myeloid Leukemia
Session II: Myelodysplastic Syndromes
Session III: Myeloproliferative Neoplasms
Session IV: Acute Lymphoblastic Leukemia
Session V: Acute Myeloid Leukemia
Plenary Sessions
Breakfast with the Expert
Session VI: Multiple Myeloma
Program of Events
Session VIII: Non-Hodgkin Lymphoma
Session IX: Chronic Lymphocytic Leukemia
Session X: Research Topics

Playback speed

10 seconds

CLL Next Questions: Biology, MRD, Risk Stratification, New Molecules, Subsequent Lines & CAR T-cells

By Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018) FEATURING Florencia Cymbalista

428 views

October 25, 2018

Comments 0

The First Treatment Choice Matters

Feat. A. Ip

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Session IX: Chronic Lymphocytic Leukemia

CLL State of the Art Update: Biology, Therapeutic Landscape, Infecti…

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

F. Cymbalista

380 views

Evolving Firstline Treatment for Patients with CLL

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

N. Jain

374 views

DEBATE: The Chemoimmunotherapy Era in CLL is Over

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

P. Thompson

242 views

DEBATE: Chemoimmunotherapy in CLL is Over? No

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

B. Eichhorst

249 views

Optimal Sequencing of Molecules in the Treatment in Chronic Lymphocy…

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

A. Mato

1.2K views

Risk of Infection with Ibrutinib in Patients with CLL: A Systematic …

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

S. Ball

384 views

CLL Next Generation Reversible BTK Inhibitor, For Overcoming Acquire…

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

B. Brandhuber

289 views

CLL Next Questions: Biology, MRD, Risk Stratification, New Molecules…

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

F. Cymbalista

428 views